Why do both leading pharmaceutical companies—as well as biotech companies with only an A round of capital in the bank—turn to Healogix? They all know that Healogix gets it and gets it done. Healogix clients can take our insight to the bank, both figuratively and literally.

What can our clients look forward to?

COMMERCIALLY-CENTRIC

At Healogix, we are unabashedly commercially-focused. In our industry, success is ultimately driven by sales and market share and that is clearly linked to how a product is positioned, perceived, and used. We relentlessly narrow in on factors that will drive customers to embrace your product and believe this is the best way to create an integrated marketing strategy. And integration will maximize return on your marketing research investment.

360° PERSPECTIVE

Healogix synthesizes the perspectives of every decision maker—physicians, patients, payers, advocates, KOLs, etc. In most cases we also incorporate the clinical, regulatory, commercial, sales, marketing, business insight and the executive team.

It is common practice to evaluate the opinions and behaviors or each stakeholder independently. What that leaves behind is the ability to readily assess the interactions between stakeholders. Our best practice is to use a common platform for gathering information that facilitates integration and allows executives to assess strategy options and their implications across all stakeholders—leading to better decision made more quickly.

A TAILORED APPROACH

Every engagement we undertake is custom tailored to the unique needs, timing, operating style, and financial resources of a client. We have an unparalleled depth of industry, therapeutic category, commercial, and methodological expertise. Our methods range from qualitative interviewing to the most sophisticated analytical tools available in the world of marketing science. We also have a breadth of geographical reach and efficient research partners that help us execute our work quickly and cost effectively.

SERVICING CLIENTS AROUND THE WORLD

 Since its inception, Healogix has been conducting global studies, both qualitative and quantitative, with  physicians, patients and payers. We have established strategic partners in Europe, Asia and Latin America that help us with the local execution of our clients’ projects. Additional partners are evaluated on an ongoing basis as new countries are added to our clients’ studies. Each of our partners, leaders in their own right, offers Healogix the full suite of services. More importantly they guarantee us the quality we demand for our clients.

 Each global project is assigned to a senior member of the Healogix team in the US and they are responsible for facilitation of the global execution. Their role is simple, to hold your hand and take the lead as you navigate the nuances of the local markets. Translations, cultural differences, reimbursement issues, all of these things are explained, taken into account and dealt with for you, quickly and efficiently.  You can be assured that our expertise in global research will provide impactful, meaningful results that help drive your global strategies.

 OUR COMMITMENT

Every client engagement is exactly that: a mutual commitment to work together towards a common set of goals and objectives and every engagement is led and directly managed by a principle of Healogix.

We work closely and iteratively with our clients to ensure we are developing and executing engagements that will really address their issues and questions. Our scale, scope, and knowledge allow us to address commercialization related issues that no one else can and integrate and deliver results to clients that are strategically and commercially pragmatic.

EARLY STAGE OPPORTUNITY AND PRODUCT ASSESSMENT

Increasingly the battle for market share for a new product is won or lost before Phase III. We have worked with both large and small companies to help them define the Phase III clinical endpoints with the greatest commercial impact across all of the stakeholders. Our models allow you to assess alternative clinical development strategies and their implications on adoption and revenue potential.

LICENSING AND VALUATION

Effective licensing requires both discipline and good information. We quickly identify the criteria required to successfully compete in the market in which a licensed product will be launched. We convert these criteria into thresholds for evaluating and valuing licensing opportunities in therapeutic categories of strategic interest. This plus the combination of our experience and industry knowledge will help you confidently make Go / No Go or valuation decisions.

DURABLE DIFFERENTIATION: SEGMENTATION, POSITIONING, AND MESSAGE OPTIMIZATION

Pharmaceutical marketing boils down to three simple questions.

• Who do I talk to?
• What do I say?
• How do I say it?

At Healogix, we generate significant value and better ROI when we answer these questions in concert. In a payer-driven world, being best or being first is no longer good enough. Durable differentiation is the new bench mark for marketing. Our approach aligns stake holder requirements, unique benefits, and an optimal message to create durable differentiation.

PRICING AND MARKET ACCESS

There’s an old adage, “He who has the gold writes the rules.” In pharmaceutical marketing that is the third-party payer and the consumer. We help companies develop the pharmaeconomic case to support the adoption and pricing of new products. Here, more than anywhere, we focus on establishing a 360 degree perspective to clarify the potential value of a new product. For products already on the market, we assess the impact of generics and lifecycle and patent extension strategies.

BRAND REJUVENATION

Only about 10% of the products marketed in pharma ever deliver a positive ROI. This is compounded when companies underestimate the inertia of an entrenched brand. Too often we see companies rely too heavily on sales and outmoded marketing models when they need to make a real strategic break.

We have worked with a number of under-performing brands, or brands that are in crisis. While sensitive to a brand’s past, our focus is on the future. We rejuvenate brands by asking three fundamental questions using our 360° perspective:

• What’s the opportunity?
• How do we win?
• What’s it worth?

No guarantees, but our approach has repeatedly identified new and unique ways to position underperforming brands resulting in renewed growth and increased market share.

LIFE-CYCLE MANAGEMENT / FULL PRODUCT LIFECYCLE VIEW

The days of extending a product’s revenue stream by just adding an XR or CR to an established brand to are either dead or, at minimum, in the Marketing CCU. Payers are clearly putting an end to that with “Tier & Steer.” Physicians and patients are being punished financially by selecting products with a negligible or incremental advantage. Marketers interested in maximizing or extending product revenues need to be able to demonstrate real differentiation to assure reimbursement and revenue viability. Through future landscaping, we have helped clients identify the zones of opportunity and identify new product formulations, product combinations, or licensing opportunities that would be successful in a world increasingly challenged by reimbursement.